US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist
  • 3.230
  • -0.720-18.23%
Close Mar 31 16:00 ET
  • 3.390
  • +0.160+4.95%
Pre 06:52 ET
96.13MMarket Cap-5.82P/E (TTM)

About Telomir Pharmaceuticals Company

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm’s initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Miami, FL.

Company Profile

SymbolTELO
Company NameTelomir Pharmaceuticals
Listing DateFeb 9, 2024
Issue Price7.00
Founded2021
CEOMr. Erez Aminov
MarketNASDAQ
Employees5
Fiscal Year Ends12-31
Address100 SE 2nd Street,Suite 2000-1009
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33131
Phone1-786-396-6723
Websitehttp://www.telomirpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Erez Aminov
  • Chairman of the Board and Chief Executive Officer
  • --
  • Michelle Yanez, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer, Treasurer, and Secretary
  • --
  • Matthew Pratt Whalen
  • Independent Director
  • --
  • Edward MacPherson
  • Independent Director
  • --
  • Dr. Matthew Paul Del Giudice, M.D.
  • Independent Director
  • --
  • Dr. Craig Eagle, M.D.
  • Independent Director
  • --

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.96%
Sample Name
Sample Code
 +24.59%
Sample Name
Sample Code
 +20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 10.440
Sample Name
Sample Code
 222.130
Sample Name
Sample Code
 127.130
4
Meritage Homes
MTH
70.880
5
Lennar Corp
LEN
114.780
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 222.130
Sample Name
Sample Code
 61.710
Sample Name
Sample Code
 98.700
4
Qualcomm
QCOM
153.610
5
Taiwan Semiconductor
TSM
166.000
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 15.0100
Sample Name
Sample Code
 2.730
Sample Name
Sample Code
 6.090
4
Digihost Technology
DGHI
1.320
5
Hut 8
HUT
11.620
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -